DOCSLIB.ORG

Laboratory Diagnostics of Inherited Platelet Disorders

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Laboratory Diagnostics of Inherited Platelet Disorders DOI 10.1515/cclm-2014-0131 Clin Chem Lab Med 2014; 52(8): 1091–1106 Review Cecilia Carubbia, Elena Massellia, Antonio Nouvenne, Domenico Russo, Daniela Galli, Prisco Mirandola, Giuliana Gobbi* and Marco Vitale* Laboratory diagnostics of inherited platelet disorders Abstract: Inherited platelet disorders (IPDs) are the gen- Introduction eral and common denomination of a broad number of different rare and congenital pathologies affecting plate- Inherited platelet disorders (IPDs) are rare, congenital dis- lets. Even if these disorders are characterized by widely eases of platelet number and/or function characterized by a heterogeneous clinical presentations, all of them are com- widely heterogeneous clinical presentation and a challeng- monly present as defects in hemostasis. Platelet num- ing diagnostic work-up. They usually present as primary ber and/or function are affected by a wide spectrum of hemostatic defects that may range from a prolonged bleed- severity. IPDs might be associated with defects in bone ing after trauma or surgery in adulthood to life-threatening, marrow megakaryocytopoiesis and, rarely, with somatic spontaneous hemorrhages (gastrointestinal, genitourinary defects. Although in the last few years new insights in the or even intracranial) occurring early in life [1, 2]. genetic bases and pathophysiology of IPDs have greatly Defects in platelet function are frequently accom- improved our knowledge of these disorders, much effort panied by abnormalities in bone marrow megakaryocy- still needs to be made in the field of laboratory diagnosis. topoiesis, resulting in reduced platelet counts and altered This review discusses the laboratory approach for the dif- platelet morphology. ferential diagnosis of the most common IPDs, suggesting a In some cases, platelet disorders are associated with common multistep flowchart model which starts from the somatic defects, such as reduced or delayed pigmentation simpler test (platelet count) ending with the more selec- Hermansky-Pudlak syndrome (HPS), hearing loss, renal tive and sophisticated analyses. impairment and/or cataracts (MYH9-related diseases), eczema and susceptibility to infections Wiskott-Aldrich Keywords: bleeding; laboratory tests; platelets; rare syndrome (WAS), limb abnormalities (thrombocytopenias diseases. associated with skeletal defects). While the process of IPDs characterization significantly aCecilia Carubbi and Elena Masselli contributed equally to this work. contributed to our understanding of the genetic bases of *Corresponding authors: Giuliana Gobbi, PhD, Department of megakaryocytopoiesis and platelet function, unfortunately Biomedical, Biotechnological and Translational Sciences (S.Bi. little progress has been made in the field of laboratory diag- Bi.T.), University of Parma, Ospedale Maggiore, Via Gramsci, 14, nostics of these diseases. In fact, diagnosis of the majority 43100 Parma, Italy, Phone: +39 0521 033142, Fax: +39 0521 033033, E-mail: [email protected]; Marco Vitale, MD, Department of IPDs still primarily relies on personal and family history, of Biomedical, Biotechnological and Translational Sciences (S.Bi. co-morbidities (i.e., skeletal defects), peripheral blood Bi.T.), University of Parma, Ospedale Maggiore, Via Gramsci, 14, smear analysis and genetic testing, when available [3, 4]. 43100 Parma, Italy, Phone: +39 0521 033032, This review will discuss the diagnostic algorithm – Fax: +39 0521 033033, E-mail: [email protected] focusing on laboratory tests – for the most common IPDs; Cecilia Carubbi, Elena Masselli, Daniela Galli and Prisco Mirandola: diseases are presented on the basis of their involvement of Department of Biomedical, Biotechnological and Translational Sciences (S.Bi.Bi.T.), Anatomy and Histology Unit, University of platelet count, function, or both. Parma, Ospedale Maggiore, Parma, Italy Antonio Nouvenne: Department of Clinical and Experimental Medicine, University of Parma, Ospedale Maggiore, Parma, Italy Disorders of platelet number Domenico Russo: Unit of Blood Diseases and Cell Therapies, University of Brescia, AO Spedali Civili Brescia, Brescia, Italy This group encompasses MYH9-related disorders, con- genital amegakaryocytic thrombocytopenia (CAMT), 1092 Carubbi et al.: Inherited platelet disorders diagnosis thrombocytopenias associated with skeletal defects, Platelet count is usually below 50 × 109/L and their size is X-linked thrombocytopenia (XLT) with dyserythropoiesis, normal [10]. familial platelet disorders with predisposition to acute Bone marrow aspirate reveals marked megakaryo- leukemia (FDP/AML), benign mediterranean macrothrom- cytic hypoplasia that may progress to bone marrow bocyopenia (BBM), familial thrombocytopenia 2 (THC2). failure. Mutations of the thrombopoietin (TPO) recep- Genetic analysis is the sole specific laboratory test for tor (c-mpl) underlie this disease and can be detected by these IPDs and is currently clinically available for CAMT, genetic testing [11]. thrombocytopenia with absent radii (TAR), thrombocyto- penia with radio-ulnar synostosis (ATRUS), XLT with dys- erythropoiesis and FDP/AML [5] (Table 1). Thrombocytopenias associated with skeletal Beyond genetic testing, diagnosis is essentially based defects on family history (usually relevant in autosomal domi- nant disorders such as MYH9-related disorders, ATRUS, This group of IPDs encompasses three different thrombo- Di George/Velocardiofacial syndrome (VCFS), thrombo- cytopenias associated with peculiar skeletal defects: TAR, cythopenia with predisposition to leukemia, BBM, THC ATRUS and Di George/VCFS. 2) and presence of patognomonic-associated defects TAR is an autosomal recessive disease that manifests affecting other organs (see Figures 1 and 2). During the early in life with a bleeding diathesis that tends to amelio- laboratory diagnostic work-up, a key role is detained by rate with time due to a progressive increase of the platelet peripheral blood smear analysis for platelet morphology count. Diagnosis is straightforward given the presence (i.e., presence of macrothrombocytes – as in the case of of the typical bilateral radial anomalies that affect TAR MYH9-related disorders and BMM – or detection of spin- patients. Bone marrow megakaryocytes are reduced, but dle-shaped Döhle leukocyte inclusions, as in the case of platelet size and function are normal. Defects in the TPO/ MHY9-related diseases) [6]. c-mpl signaling may be found with appropriate genetic tests [12]. ATRUS is an autosomal dominant amegakaryocitic MYH9-related disorders thrombocytopenia associated with aplastic anemia, radio-ulnar synostosis, clinodactyly, syndactyly, hip- This term indicates a group of autosomal dominant dysplasia and sensorineural hearing loss. Like TAR, thrombocytopenias (May-Hegglin anomaly, Sebastian also ATRUS presents with severe thrombocytopenia Syndrome, Fechtner Syndrome and Epstein syndrome) at birth that may improve with time [13]. Detection of caused by mutations within the MYH9 gene, encoding for mutations of HOXA11, a member of the homeobox genes the non-muscle myosin IIA heavy chain which is part of encoding for proteins that detain a central role in skel- the contractile cytoskeleton of megakaryocytes, platelets etal development and hematopoiesis, allows final diag- and neutrophils [7, 8]. nosis [14]. As a result, bone marrow megakaryocitopoiesis is Di George/VCFS is an autosomal dominant macro- ineffective and platelets display abnormally larger dimen- thrombocytopenia typified by cardiac abnormalities, cleft sions (macrothrombocytes). Platelet aggregation tests palate, thymic aplasia, mental retardation, disimmunity. are normal. Thrombocytopenia ranges from 20 × 109/L to The gene involved, usually with a hemizygous loss of 130 × 109/L, but bleeding phenotype is usually mild. Diag- allele, is GP1BB, located at 22q11, one of the three genes nosis is suggested by peculiar co-morbidities, such as sen- defective in Bernard-Soulier syndrome (BSS). Thus, clini- sorineural hearing loss, cataracts, glomerulonephritis, cal manifestations are usually mild and may overlap with but definitive identification of this IPD requires the dem- heterozygous BSS. Again, clinical diagnosis is suggested onstration of a causative mutation within MHY9 [9]. by the relevant co-morbidities and requires confirmation by genetic testing [15]. Congenital amegakaryocytic thrombocyto- penia (CAMT) X-linked thrombocytopenia with dyserythropoiesis CAMT is an autosomal recessive disorder characterized by symptomatic thrombocytopenia manifesting early This X-linked platelet disorder is due to mutations of the in life, occasionally with a severe bleeding phenotype. GATA1 gene, encoding for the transcription factor GATA1, Carubbi et al.: Inherited platelet disorders diagnosis 1093 Table 1 Classification of inherited platelet disorders and laboratory tests currently available. Gene (location) Inheritance Genetic testing Lab test(s) clinically available MYH9-related disorders MYH9 (22q12-13) AD Yes PLT count Peripheral blood smear Platelet aggregometry Congenital amegakaryocytic c-MPL (1p34) AR Yes PLT count thrombocytopenia Peripheral blood smear Bone marrow aspirate Thrombocytopenias associated Y19 (1q21.1), HOXA11 (7p15-p14.2), AD/AR Yes PLT count with skeletal defects GPIBB (22q11) (Bone marrow aspirate) X-linked thrombocytopenia with GATA1 (Xp11.23) X-linked Yes PLT count dyserythropoiesis Peripheral blood smear Bone marrow aspirate Familial platelet disorders with RUNX1 (21q22) AD Yes PLT count predisposition to leukemia Peripheral
Load more

Recommended publications
  • MYH9-Related Platelet Disorders
    Reprinted with permission from Thieme Medical Publishers (Semin Thromb Hemost 2009;35:189-203) Homepage at www.thieme.com MYH9-Related Platelet Disorders Karina Althaus, M.D.,1 and Andreas Greinacher, M.D.1 ABSTRACT Myosin heavy chain 9 (MYH9)-related platelet disorders belong to the group of inherited thrombocytopenias. The MYH9 gene encodes the nonmuscle myosin heavy chain IIA (NMMHC-IIA), a cytoskeletal contractile protein. Several mutations in the MYH9 gene lead to premature release of platelets from the bone marrow, macro- thrombocytopenia, and cytoplasmic inclusion bodies within leukocytes. Four overlapping syndromes, known as May-Hegglin anomaly, Epstein syndrome, Fechtner syndrome, and Sebastian platelet syndrome, describe different clinical manifestations of MYH9 gene mutations. Macrothrombocytopenia is present in all affected individuals, whereas only some develop additional clinical manifestations such as renal failure, hearing loss, and presenile cataracts. The bleeding tendency is usually moderate, with menorrhagia and easy bruising being most frequent. The biggest risk for the individual is inappropriate treatment due to misdiagnosis of chronic autoimmune thrombocytopenia. To date, 31 mutations of the MYH9 gene leading to macrothrombocytopenia have been identified, of which the upstream mutations up to amino acid 1400 are more likely associated with syndromic manifestations than the downstream mutations. This review provides a short history of MYH9-related disorders, summarizes the clinical and laboratory character- istics, describes a diagnostic algorithm, presents recent results of animal models, and discusses aspects of therapeutic management. KEYWORDS: MYH9 gene, nonmuscle myosin IIA, May-Hegglin anomaly, Epstein syndrome, Fechtner syndrome, Sebastian platelet syndrome, macrothrombocytopenia The correct diagnosis of hereditary chronic as isolated platelet count reductions or as part of thrombocytopenias is important for planning appropri- more complex clinical syndromes.
    [Show full text]
  • Thrombocytopenia-Absent Radius Syndrome
    Thrombocytopenia-absent radius syndrome Description Thrombocytopenia-absent radius (TAR) syndrome is characterized by the absence of a bone called the radius in each forearm and a shortage (deficiency) of blood cells involved in clotting (platelets). This platelet deficiency (thrombocytopenia) usually appears during infancy and becomes less severe over time; in some cases the platelet levels become normal. Thrombocytopenia prevents normal blood clotting, resulting in easy bruising and frequent nosebleeds. Potentially life-threatening episodes of severe bleeding ( hemorrhages) may occur in the brain and other organs, especially during the first year of life. Hemorrhages can damage the brain and lead to intellectual disability. Affected children who survive this period and do not have damaging hemorrhages in the brain usually have a normal life expectancy and normal intellectual development. The severity of skeletal problems in TAR syndrome varies among affected individuals. The radius, which is the bone on the thumb side of the forearm, is almost always missing in both arms. The other bone in the forearm, which is called the ulna, is sometimes underdeveloped or absent in one or both arms. TAR syndrome is unusual among similar malformations in that affected individuals have thumbs, while people with other conditions involving an absent radius typically do not. However, there may be other abnormalities of the hands, such as webbed or fused fingers (syndactyly) or curved pinky fingers (fifth finger clinodactyly). Some people with TAR syndrome also have skeletal abnormalities affecting the upper arms, legs, or hip sockets. Other features that can occur in TAR syndrome include malformations of the heart or kidneys.
    [Show full text]
  • TAR Syndrome, a Rare Case Report with Cleft Lip/Palate a Naseh, a Hafizi, F Malek, H Mozdarani, V Yassaee
    The Internet Journal of Pediatrics and Neonatology ISPUB.COM Volume 14 Number 1 TAR Syndrome, a Rare Case Report with Cleft Lip/Palate A Naseh, A Hafizi, F Malek, H Mozdarani, V Yassaee Citation A Naseh, A Hafizi, F Malek, H Mozdarani, V Yassaee. TAR Syndrome, a Rare Case Report with Cleft Lip/Palate. The Internet Journal of Pediatrics and Neonatology. 2012 Volume 14 Number 1. Abstract TAR (Thrombocytopenia-Absent Radius) is a clinically –defined syndrome characterized by hypomegakarocytic thrombocytopenia and bilateral absence of radius in the presence of both thumbs. We describe a female neonate as a rare case of TAR syndrome with orofacial cleft. Bone marrow aspiration of the patient revealed a cellular marrow with marked reduction of megakaryocytes. Our clinical observation is consistent with TAR syndrome. However, other syndromes with cleft lip/palate and radial aplasia like Roberts syndrome (tetraphocomelia), Edwards syndrome and Fanconi and sc phocomelia (which has less degree of limb reduction) should be considered. Our cytogenetic study excludes other overlapping chromosomal syndromes. RBM8A analysis may reveal nucleotide alteration, leading to definite diagnosis. Our objective is adding this cleft lip and cleft palate to the literature regarding TAR syndrome. - Eva Klopocki, Harald Schulz, Gabriele Straub,Judith Hall,Fabienne Trotier, et al(February 2007) ;Complex inheritance pattern Resembeling Autosomal Recessive Inheritance Involving a Microdeletion in Thrombocytopenia-Absent Radius Syndrome.The American Journal of Human Genetics 80:232-240 INTRODUCTION syndrome. The hemorrhage happens during the first 14 TAR is a clinically-defined syndrome characterized by months of life. Hedberg and associates concluded in a study thrombocytopenia and bilateral radial bone aplasia in the that 18 of 20 deaths in 76 patients were due to hemorrhagic forearm with thumbs present.
    [Show full text]
  • (TAR) Syndrome Without Significant Thrombocytopenia
    Open Access Case Report DOI: 10.7759/cureus.10557 Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia Jael Cowan 1 , Taral Parikh 1 , Rajdeepsingh Waghela 1 , Ricardo Mora 2 1. Pediatrics, Woodhull Medical Center, Brooklyn, USA 2. Neonatology, Woodhull Medical Center, Brooklyn, USA Corresponding author: Jael Cowan, [email protected] Abstract Thrombocytopenia with absent radii (TAR) syndrome is a rare genetic syndrome that occurs with a frequency of about 0.42 cases per 100,000 live births. It is characterized by hypo-megakaryocytic thrombocytopenia with bilateral absent radii and the presence of both thumbs. The thrombocytopenia is initially very severe, manifesting in the first few weeks to months of life, but subsequently improves with time to reach near normal values by one to two years of age. We present a case of a newborn with TAR syndrome with an atypical presentation of mild thrombocytopenia in the first week of life, with early normalization of platelet counts in the neonatal period. The patient deviates from the normal pattern in which 95% of patients with TAR syndrome usually develop significant thrombocytopenia (platelet counts of less than 50 x 10 9 platelets/L) within the first four months of life. Additionally, the absence of hypo-megakaryocytes on peripheral smear sets this patient apart from the typical cases of TAR syndrome. TAR syndrome is often associated with significant morbidity and mortality secondary to severe thrombocytopenia, which occurs with the highest frequency in the first 14 months of life. The most common cause of mortality is due to a severe hemorrhagic event occurring in the brain, gastrointestinal tract, and other organs.
    [Show full text]
  • Diagnosis of Inherited Platelet Disorders on a Blood Smear
    Journal of Clinical Medicine Article Diagnosis of Inherited Platelet Disorders on a Blood Smear Carlo Zaninetti 1,2,3 and Andreas Greinacher 1,* 1 Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, 17489 Greifswald, Germany; [email protected] 2 University of Pavia, and IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy 3 PhD Program of Experimental Medicine, University of Pavia, 27100 Pavia, Italy * Correspondence: [email protected]; Tel.: +49-3834-865482; Fax: +49-3834-865489 Received: 19 January 2020; Accepted: 12 February 2020; Published: 17 February 2020 Abstract: Inherited platelet disorders (IPDs) are rare diseases featured by low platelet count and defective platelet function. Patients have variable bleeding diathesis and sometimes additional features that can be congenital or acquired. Identification of an IPD is desirable to avoid misdiagnosis of immune thrombocytopenia and the use of improper treatments. Diagnostic tools include platelet function studies and genetic testing. The latter can be challenging as the correlation of its outcomes with phenotype is not easy. The immune-morphological evaluation of blood smears (by light- and immunofluorescence microscopy) represents a reliable method to phenotype subjects with suspected IPD. It is relatively cheap, not excessively time-consuming and applicable to shipped samples. In some forms, it can provide a diagnosis by itself, as for MYH9-RD, or in addition to other first-line tests as aggregometry or flow cytometry. In regard to genetic testing, it can guide specific sequencing. Since only minimal amounts of blood are needed for the preparation of blood smears, it can be used to characterize thrombocytopenia in pediatric patients and even newborns further.
    [Show full text]
  • Gri Trombosit Sendromu
    Cukurova Medical Journal Cukurova Med J 2017;42(2):360-362 ÇUKUROVA ÜNİVERSİTESİ TIP FAKÜLTESİ DERGİSİ DOI: 10.17826/cutf.322967 OLGU SUNUMU / CASE REPORT Gray platelet syndrome Gri trombosit sendromu Fatima Ayaz1, Saeed Bin Ayaz2, Sunila Tashfeen2, Muhammad Furrukh1 1Benazir Bhutto Hospital, Rawalpindi, Punjab, Pakistan 2Combined Military Hospital, Okara, Punjab, Pakistan Cukurova Medical Journal 2017;42(2):360-362 Abstract Öz Gray platelet syndrome (GPS) is an autosomal recessive Gri trombosit (platelet) sendromu (GPS), trombositopeni disorder characterized by thrombocytopenia and defective ve ışık mikroskopunda soluk görünen kusurlu platelets that appear pale on light microscope. Patients trombositlerle karakterize, otozomal resesif geçişli bir present with easy bruisability, nose bleeds, menorrhagia hastalıktır. Hastalarda kolay morarma, burun kanaması, and prolonged bleeding. There is no specific treatment for menoraji ve uzun kanamalar görülmektedir. GPS için GPS and the management includes anticipating risks and spesifik bir tedavi bulunmamaktadır dolayısı ile hastalığa preventing bleeding by avoiding drugs that impair platelet karşı, riskleri öngörmek ve kanamanın önlenmesi function. We present here report of a case who presented için trombosit fonksiyonunu bozan ilaçlardan kaçınmak with repeated episodes of abnormal bleeding and was gerekmektedir. Bu olgu sunumunda, tekrarlayan anormal found to have GPS. kanama atakları olan ve GPS bulgusu bulunan bir vaka sunulmaktadır. Key words: Bleeding disorder, gray platelet syndrome, Anahtar
    [Show full text]
  • 1Q21.1 Deletion and a Rare Functional Polymorphism in Siblings with Thrombocytopenia-Absent Radius–Like Phenotypes
    Downloaded from molecularcasestudies.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press COLD SPRING HARBOR Molecular Case Studies | RESEARCH ARTICLE 1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius–like phenotypes Seth A. Brodie,1 Jean Paul Rodriguez-Aulet,2 Neelam Giri,2 Jieqiong Dai,1 Mia Steinberg,1 Joshua J. Waterfall,3 David Roberson,1 Bari J. Ballew,1 Weiyin Zhou,1 Sarah L. Anzick,3 Yuan Jiang,3 Yonghong Wang,3 Yuelin J. Zhu,3 Paul S. Meltzer,3 Joseph Boland,1 Blanche P. Alter,2 and Sharon A. Savage2 1Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA; 2Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, 3Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA Abstract Thrombocytopenia-absent radii (TAR) syndrome, characterized by neonatal thrombocytopenia and bilateral radial aplasia with thumbs present, is typically caused by the inheritance of a 1q21.1 deletion and a single-nucelotide polymorphism in RBM8A on the nondeleted allele. We evaluated two siblings with TAR-like dysmorphology but lacking thrombocytopenia in infancy. Family NCI-107 participated in an IRB-approved cohort study and underwent comprehensive clinical and genomic evaluations, including aCGH, whole- exome, whole-genome, and targeted sequencing. Gene expression assays and electromo- bility shift assays (EMSAs) were performed to evaluate the variant of interest. The previously identified TAR-associated 1q21.1 deletion was present in the affected siblings and one healthy parent. Multiple sequencing approaches did not identify previously described TAR-associated SNPs or mutations in relevant genes.
    [Show full text]
  • Platelet Function Disorders
    TREATMENT OF HEMOPHILIA APRIL 2008 • NO 19 PLATELET FUNCTION DISORDERS Second Edition Anjali A. Sharathkumar Amy Shapiro Indiana Hemophilia and Thrombosis Center Indianapolis, U.S.A. Published by the World Federation of Hemophilia (WFH), 1999; revised 2008. © World Federation of Hemophilia, 2008 The WFH encourages redistribution of its publications for educational purposes by not-for-profit hemophilia organizations. In order to obtain permission to reprint, redistribute, or translate this publication, please contact the Communications Department at the address below. This publication is accessible from the World Federation of Hemophilia’s website at www.wfh.org. Additional copies are also available from the WFH at: World Federation of Hemophilia 1425 René Lévesque Boulevard West, Suite 1010 Montréal, Québec H3G 1T7 CANADA Tel. : (514) 875-7944 Fax : (514) 875-8916 E-mail: [email protected] Internet: www.wfh.org The Treatment of Hemophilia series is intended to provide general information on the treatment and management of hemophilia. The World Federation of Hemophilia does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. Dose schedules and other treatment regimes are continually revised and new side effects recognized. WFH makes no representation, express or implied, that drug doses or other treatment recommendations in this publication are correct. For these reasons it is strongly recommended that individuals seek the advice of a medical adviser and/or consult printed instructions provided by the pharmaceutical company before administering any of the drugs referred to in this monograph. Statements and opinions expressed here do not necessarily represent the opinions, policies, or recommendations of the World Federation of Hemophilia, its Executive Committee, or its staff.
    [Show full text]
  • Soonerstart Automatic Qualifying Syndromes and Conditions
    SoonerStart Automatic Qualifying Syndromes and Conditions - Appendix O Abetalipoproteinemia Acanthocytosis (see Abetalipoproteinemia) Accutane, Fetal Effects of (see Fetal Retinoid Syndrome) Acidemia, 2-Oxoglutaric Acidemia, Glutaric I Acidemia, Isovaleric Acidemia, Methylmalonic Acidemia, Propionic Aciduria, 3-Methylglutaconic Type II Aciduria, Argininosuccinic Acoustic-Cervico-Oculo Syndrome (see Cervico-Oculo-Acoustic Syndrome) Acrocephalopolysyndactyly Type II Acrocephalosyndactyly Type I Acrodysostosis Acrofacial Dysostosis, Nager Type Adams-Oliver Syndrome (see Limb and Scalp Defects, Adams-Oliver Type) Adrenoleukodystrophy, Neonatal (see Cerebro-Hepato-Renal Syndrome) Aglossia Congenita (see Hypoglossia-Hypodactylia) Aicardi Syndrome AIDS Infection (see Fetal Acquired Immune Deficiency Syndrome) Alaninuria (see Pyruvate Dehydrogenase Deficiency) Albers-Schonberg Disease (see Osteopetrosis, Malignant Recessive) Albinism, Ocular (includes Autosomal Recessive Type) Albinism, Oculocutaneous, Brown Type (Type IV) Albinism, Oculocutaneous, Tyrosinase Negative (Type IA) Albinism, Oculocutaneous, Tyrosinase Positive (Type II) Albinism, Oculocutaneous, Yellow Mutant (Type IB) Albinism-Black Locks-Deafness Albright Hereditary Osteodystrophy (see Parathyroid Hormone Resistance) Alexander Disease Alopecia - Mental Retardation Alpers Disease Alpha 1,4 - Glucosidase Deficiency (see Glycogenosis, Type IIA) Alpha-L-Fucosidase Deficiency (see Fucosidosis) Alport Syndrome (see Nephritis-Deafness, Hereditary Type) Amaurosis (see Blindness) Amaurosis
    [Show full text]
  • Cytogenetics
    CYTOGENETICS Techniques Cytogenetic strategy Anna Sowińska-Seidler, Phd CYTOGENETICS • Classical • Molecular - Karyotype analysis - Molecular probes - Banding techniques - FISH, aCGH Elementary fibre Chromatin fibre Laemi loop Chromatid Metaphase chromosome Chromosome structure Chromosome types Chromosome types in human: Metacentric Submetacentric Akrocentric Human chromosome groups A 1-3 big metacentric chromosomes B 4-5 big submetacentric chromosomes C 6-12 and X medium submetacentric chromosomes D 13-15 big acrocentric chromosomes E 16-18 small submetacentric chromosomes F 19-20 small metacentric chromosomes G 21-22 and Y small acrocentric chromosomes A B C D E F G Aberrations autosomes sex chromosomes Aberrations numerical structural Numerical abnormalities of chromosomes Polyploidy Aneuploidy Triploidy Tetraploidy Trisomy Monosomy 3n 4n 2n +1 2n - 1 Numerical chromosomal abnormalities Polyploidy - Triploidy (69,XXX, XXY or XYY) 1-3% of all conceptions; amost never live born; do not survive Aneuploidy (autosomes) - Nullisomy (missing a pair of homologs) Pre-implantation lethal - Monosomy (one chromosome missing) Embryonic lethal - Trisomy (one extra chromosome) Usually lethal at embryonic or fetal stages, but trisomy 13 (Patau syndrome) and trisomy 18 (Edwards syndrome) could be live born and trisomy 21 (Down syndrome) Aneuploidy (sex chromosomes) - Additional sex chromosomes (47, XXX; 47, XXY; 47, XYY) present relatively minor problems, with normal lifespan - Lacking a sex chromosome 45, X = Turner syndrome, About 99% of cases abort
    [Show full text]
  • Thrombocytopenia-Absent Radius (TAR) Syndrome Service At
    Thrombocytopenia-Absent Radius Syndrome (TAR) Contact details: Clinical Background and Genetics Bristol Genetics Laboratory Southmead Hospital . Thrombocytopenia-absent radius (TAR) syndrome is characterised by Bristol, BS10 5NB hypomegakaryocytic thrombocytopenia and bilateral radial aplasia in Enquiries: 0117 414 6168 the presence of both thumbs. FAX: 0117 414 6464 . These characteristic patterns differentiate TAR syndrome from other Email: [email protected] conditions with involvement of the radius, namely Holt-Oram Head of department: syndrome, Roberts syndrome and Fanconi Anaemia in which the Eileen Roberts FRCPath thumb is usually absent or severely hypoplastic. Additional skeletal features associated with TAR syndrome include Consultant Lead for shortening and, less commonly, aplasia of the ulna and/or humerus. Molecular Genetics: . The hands may show limited extension of the fingers, radial deviation Maggie Williams FRCPath and hypoplasia of the carpal and phalangeal bones. Service Lead: . The majority of TAR syndrome cases develop when an individual has Laura Yarram-Smith a deletion of the RBM8A gene (chromosome 1q21.1) on one [email protected] chromosome and a RBM8A hypomorphic SNP on the other allele.Two RBM8A hypomorphic SNPs have been identified, that Sample Required: when in trans with an RBM8A deletion account for approximately 96% Adult: 5mls blood in EDTA of TAR syndrome cases (Nat Genet. 2012 Feb 26;44(4):435-9). Paediatric: at least 1ml EDTA . A minority of TAR syndrome cases are explained by a null mutation in (preferably >2ml). Given possible the RBM8A gene in trans with a RBM8A hypomorphic SNP on the difficulties in obtaining blood other allele. In deletion negative cases point mutation analysis of the samples from these patients a entire coding region of RBM8A gene can be completed.
    [Show full text]
  • Absent Radius (TAR) Syndrome
    orphananesthesia Anaesthesia recommendations for patients suffering from Thrombocytopenia- Absent Radius (TAR) syndrome Disease name: Thrombocytopenia- Absent Radius (TAR) syndrome ICD 10: Q87.2 Synonyms: Absent radii and thrombocytopenia, Thrombocytopenia absent radii, Thrombocytopenia absent radius syndrome, Radial Aplasia Amegakaryocytic Thrombocytopenia, Radial Aplasia Thrombocytopenia Syndrome, Radial Aplasia- Amegakaryocytic Thrombocytopenia, TAR Syndrome. Thrombocytopenia- absent radius syndrome is an uncommon congenital malformation condition characterized by bilateral absence of the radii with the presence of thumbs, and congenital thrombocytopenia. The syndrome is phenotypically variable. It is inherited in an autosomal recessive pattern caused by a 200kb deletion including or null mutation of RBM8A on one chromosome and a non-coding polymorphism in RBM8A on the other chromosome. The estimated prevalence is between 0.5- 1:100,000 and 1:240, 000 births. It affects both sexes equally. Over 150 cases have been previously reported. Medicine in progress Perhaps new knowledge Every patient is unique Perhaps the diagnostic is wrong Find more information on the disease, its centres of reference and patient organisations on Orphanet: www.orpha.net 1 Disease summary The combination of thrombocytopenia and absent radii was first described by Greenwald and Sherman in 1929, and delineated as a syndrome with a description of cardinal manifestations by Hall et al in 1969 [1,2]. The most common clinical features are: Thrombocytopenia (100%) - symptomatic in over 90% of the cases within the first four months of life. Platelet counts are usually in the range of 15 - 30x109/L in infancy and improve to almost normal range by adulthood. The thrombocytopenia is thought to be secondary to impaired bone marrow production of platelets, despite normal thrombopoetin production and slightly elevated serum levels.The number of megakaryocytes in the bone marrow is strongly reduced.
    [Show full text]